Medical Conditions in Pregnancy: Cervical Insufficiency, Hyperemesis Gravidarum, Anemia, and Diabetes

Cervical Insufficiency (Incompetent Cervix)

  • Definition and Overview: Also known as an incompetent cervix, this condition involves premature cervical dilation.
  • Diagnosis: Primarily diagnosed via ultrasound.
  • Ultrasound Findings:     * Short cervical length.     * Presence of cervical funneling.
  • Clinical Risks: Significant risk factors include miscarriage and premature birth.
  • Treatment (Cervical Cerclage):     * Prophylactic cervical cerclage is performed to strengthen the cervix.     * Removal Timing: The cerclage must be removed at 3636 to 3838 weeks of gestation or upon the onset of spontaneous labor.
  • Nursing Care and Monitoring:     * Monitor vaginal discharge continuously.     * Instruct the client to immediately report complaints of pressure, contractions, a gush of fluid, vaginal bleeding, or lower back pain.
  • Client Education and Activity Restrictions:     * Instruction on strict bedrest.     * Requirement for pelvic rest (avoiding intercourse).     * Maintain high levels of hydration.     * Avoidance of strenuous exercise and heavy lifting.
  • Risk Profile: The client is classified as HIGH RISK due to the potential for pregnancy loss or premature birth.

Hyperemesis Gravidarum

  • Definition: Excessive, prolonged vomiting during pregnancy.
  • Etiology: Possibly linked to elevated levels of the hormone human chorionic gonadotropin (hCGhCG).
  • Maternal Complications: Risk of significant weight loss, dehydration, electrolyte imbalance, and nutritional deficiency.
  • Fetal Complications: Risk of intrauterine growth restriction (IUGRIUGR), being small for gestational age (SGASGA), and preterm birth.
  • Risk Factors:     * Advanced maternal age.     * Multifetal pregnancy (e.g., twins).     * Gestational trophoblastic disease.     * Hyperthyroidism.     * Diabetes.     * Family history of hyperemesis.     * Gastrointestinal disorders.     * High levels of stress.
  • Medical Treatment:     * FDA-approved medication for nausea and vomiting in pregnancy: doxylamine/pyridoxinedoxylamine/pyridoxine (Diclegis\text{Diclegis}).     * Hospital admission may be required for IV hydration depending on the severity.
  • Nutritional Management:     * Initiate a clear liquid diet and advance to a bland diet as vomiting subsides.     * Enteral nutrition may be administered in severe cases.

Iron-Deficiency Anemia

  • Pathophysiology: Occurs due to inadequate maternal iron stores and insufficient dietary iron intake to meet the demands of pregnancy.
  • Diagnostic Criteria:     * First and Second Trimester: Hemoglobin (HgbHgb) <11.0,mg/dl< 11.0,mg/dl.     * Third Trimester: Hemoglobin (HgbHgb) <10.5,mg/dl< 10.5,mg/dl.     * Hematocrit (HCTHCT): <33%< 33\%.     * Ferritin: <12,mcg/L< 12,mcg/L.
  • Symptoms: Fatigue, weakness, and Pica (craving non-nutritive substances).
  • Risk Factors: Short intervals between pregnancies (close interval pregnancies), heavy menstrual periods prior to pregnancy, and poor dietary iron intake.
  • Treatment: Administration of supplemental elemental iron (POPO).
  • Nursing Care and Dietary Recommendations:     * Standard pregnancy recommendation for iron: 27,mg/day27,mg/day.     * Standard prenatal vitamins typically contain 30,mg/day30,mg/day.     * Therapeutic dose for diagnosed Iron-Deficiency Anemia: Increase daily intake to 60120,mg/day60-120,mg/day.
  • Patient Education for Supplementation:     * Ferrous sulfate supplements should be taken on an empty stomach.     * Consume with orange juice to increase absorption.     * Increase intake of iron-rich foods.     * Increase fiber and fluid intake to mitigate the discomfort of constipation caused by iron supplements.

Gestational Diabetes Mellitus (GDM)

  • Definition: Glucose intolerance with its first onset or recognition during pregnancy.
  • Pathophysiology: A disorder characterized by insufficient insulin production by the pancreas to move glucose from the blood into the cells.
  • Ketoacidosis: When the body cannot utilize glucose, it metabolizes protein and fat for energy, leading to the accumulation of ketones and acid (ketoacidosis).
  • Postpartum Prognosis: In instances of true GDM, glucose levels should return to normal by 66 weeks postpartum.
  • Preexisting Diabetes Mellitus:     * Clients with diabetes prior to pregnancy face an increased risk of delivering a newborn with congenital anomalies.     * Major risk for congenital anomalies stems from maternal hyperglycemia during the early embryonic period of pregnancy.

Complications and High-Risk Factors in Diabetic Pregnancy

  • Maternal Effects:     * Spontaneous abortion.     * Gestational hypertension.     * Preterm labor.     * Polyhydramnios.     * Vaginitis and urinary tract infections (UTIsUTIs).     * Birth canal injury related to the large size of the fetus.     * Ketoacidosis.
  • Fetal Effects:     * Congenital abnormalities.     * Respiratory distress syndrome (RDSRDS).     * Birth injury.     * Neonatal hypoglycemia, hypocalcemia, and hyperbilirubinemia.     * Macrosomia: Defined as a large fetus weighing 40004500,gram4000-4500,gram (approximately 9,lb9,lb or greater).     * Perinatal death.
  • High-Risk Maternal Factors for GDM:     * Maternal obesity (BMI>30BMI > 30).     * History of macrosomia.     * Maternal age >25> 25 years.     * Previous history of a child with anomalies or stillbirth.     * Personal history of GDM or family history of diabetes.     * Fasting glucose >126,mg/dl> 126,mg/dl or postprandial glucose >200,mg/dl> 200,mg/dl.

Screening and Clinical Monitoring for GDM

  • Screening Intervals:     * Early glucose tolerance testing for clients with BMI>30BMI > 30 as part of prenatal labs.     * Standard 11-hour glucose test performed at 242824-28 weeks gestation.
  • Thresholds & Follow-up:     * A 11-hour blood glucose level of 130140,mg/dl130-140,mg/dl indicates the need for a 33-hour glucose tolerance test.
  • Ongoing Monitoring:     * Monitoring urine ketones is recommended, as ketoacidosis can be fatal to the fetus.     * Education on self-monitoring of blood glucose (SMBGSMBG).     * Referrals to Endocrinology or Maternal-Fetal Medicine (MFMMFM).
  • Target Blood Glucose Levels in Pregnancy:     * Fasting: <95,mg/dl< 95,mg/dl.     * 11-hour postprandial: 130140,mg/dl130-140,mg/dl.     * 22-hour postprandial: <120,mg/dl< 120,mg/dl.

Comparison of Hypoglycemia and Hyperglycemia

  • Hypoglycemia:     * Blood glucose level: <60,mg/dl< 60,mg/dl.     * Symptoms: Nervousness, headache, hunger, irritability, blurred vision, lethargy, moist skin, pallor, sweating, and loss of consciousness.     * Corrective Measures: Consume fruit, crackers, milk, or juice. Requires adjustment of insulin or dietary intake.
  • Hyperglycemia:     * Blood glucose level: >120,mg/dl> 120,mg/dl.     * Symptoms: Polydipsia (excessive thirst), polyphagia (excessive hunger), polyuria (excessive urination), nausea, flushed/dry skin, "fruity breath," dry mouth, weight loss, deep respirations, and depressed reflexes.     * Corrective Measures: Modify dietary intake, adjust insulin, treat infections promptly, and exercise regularly.

Fetal Assessment and Management of GDM

  • Fetal Assessment Tools:     * Non-stress testing (NSTNST).     * Biophysical profile (BPPBPP) if the NSTNST is nonreactive.     * Amniocentesis to measure fetal lung maturity.     * Ultrasound to monitor growth patterns and evaluate amniotic fluid volume.
  • Pharmacological Management:     * Oral hypoglycemics: Glyburide is considered safe in pregnancy as it does not cross the placenta. Metformin is also used.     * Insulin: Dosages are tailored to individual needs, often using a sliding scale.
  • Insulin Dynamics During Pregnancy:     * Needs increase during the second trimester due to increased placental hormones and insulin resistance.     * Needs may decrease in the third trimester.     * Dosage changes during labor; IV dextrose may be necessary to support blood levels.
  • Client Education:     * Daily kick counts/fetal movement monitoring.     * Diet and exercise regimens.     * Self-administration of insulin.     * Management of hypoglycemia and hyperglycemia.     * Breastfeeding education: Infants who are exclusively breastfed have a decreased risk of developing diabetes later in life.

References

  • Leifer ED 9, Chapter 5.
  • ATI ED 12.0, PN Maternal Newborn Nursing, Chapter 8.